Chief Scientific Officer
ZRx Outcomes Research Inc., Canada
Vladimir Zah, PhD, brings 20+ years of Health Economics research and business experience. Since 2000, in various roles as Health Economist, Project Manager and Chief Investigator, Vlad has implemented more than 170 budget impact / cost effectiveness models and assessments of Rx, Dx, MolDx and digital pill, in the product phase 2, 3 and 4 settings, across various disease areas for top 20 global pharmaceutical companies, as well smaller bio and medical device companies; work supported with over 50 publications. He successfully drafted value stories behind value based agreements (VBA), drafted and finalized VBA agreements between pharma and private insurers. He has provided/edited Academy of Managed Care Practitioner (AMCP) reports for pharmaceutical clients.
Vlad resides as an active member on various International Society for Pharmacoeconomics and Outcomes Research (ISPOR) bodies.
Vlad is a visiting professor of epidemiology at Kozminski University.
